Senju Pharmaceutical Co., Ltd. - Net Worth and Insider Trading
Senju Pharmaceutical Co., Ltd. Net Worth
The estimated net worth of Senju Pharmaceutical Co., Ltd. is at least $840,551 dollars as of 2024-11-09. Senju Pharmaceutical Co., Ltd. is the 10% Owner of Eyenovia Inc and owns about 1,718,566 shares of Eyenovia Inc (EYEN) stock worth over $840,551. Details can be seen in Senju Pharmaceutical Co., Ltd.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Senju Pharmaceutical Co., Ltd. has not made any transactions after 2018-01-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Senju Pharmaceutical Co., Ltd.
Senju Pharmaceutical Co., Ltd. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Senju Pharmaceutical Co., Ltd. owns 1 companies in total, including Eyenovia Inc (EYEN) .
Click here to see the complete history of Senju Pharmaceutical Co., Ltd.’s form 4 insider trades.
Insider Ownership Summary of Senju Pharmaceutical Co., Ltd.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| EYEN | Eyenovia Inc | 2018-01-29 | 10 percent owner |
Senju Pharmaceutical Co., Ltd. Latest Holdings Summary
Senju Pharmaceutical Co., Ltd. currently owns a total of 1 stock. Senju Pharmaceutical Co., Ltd. owns 1,718,566 shares of Eyenovia Inc (EYEN) as of January 29, 2018, with a value of $840,551.
Latest Holdings of Senju Pharmaceutical Co., Ltd.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| EYEN | Eyenovia Inc | 2018-01-29 | 1,718,566 | 0.49 | 840,551 |
Holding Weightings of Senju Pharmaceutical Co., Ltd.
Senju Pharmaceutical Co., Ltd. Form 4 Trading Tracker
According to the SEC Form 4 filings, Senju Pharmaceutical Co., Ltd. has made a total of 0 transactions in Eyenovia Inc (EYEN) over the past 5 years. The most-recent trade in Eyenovia Inc is the acquisition of 100,000 shares on January 29, 2018, which cost Senju Pharmaceutical Co., Ltd. around $1,000,000.
Insider Trading History of Senju Pharmaceutical Co., Ltd.
- 1
Senju Pharmaceutical Co., Ltd. Trading Performance
GuruFocus tracks the stock performance after each of Senju Pharmaceutical Co., Ltd.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Senju Pharmaceutical Co., Ltd. is -13.98%. GuruFocus also compares Senju Pharmaceutical Co., Ltd.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Senju Pharmaceutical Co., Ltd. within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Senju Pharmaceutical Co., Ltd.'s insider trading performs compared to the benchmark.
Performance of Senju Pharmaceutical Co., Ltd.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -11.47 | | | | | |
| Relative Return to S&P 500(%) | -5.31 | | | | | |
Senju Pharmaceutical Co., Ltd. Ownership Network
Ownership Network List of Senju Pharmaceutical Co., Ltd.
Ownership Network Relation of Senju Pharmaceutical Co., Ltd.
Senju Pharmaceutical Co., Ltd. Owned Company Details
What does Eyenovia Inc do?
Who are the key executives at Eyenovia Inc?
Senju Pharmaceutical Co., Ltd. is the 10 percent owner of Eyenovia Inc. Other key executives at Eyenovia Inc include director & Chief Executive Officer Michael M Rowe , 10 percent owner Stuart M. Grant , and Chief Financial Officer John P Gandolfo .
Eyenovia Inc (EYEN) Insider Trades Summary
Over the past 18 months, Senju Pharmaceutical Co., Ltd. made no insider transaction in Eyenovia Inc (EYEN). Other recent insider transactions involving Eyenovia Inc (EYEN) include a net purchase of 1,839,115 shares made by Stuart M. Grant , a net purchase of 84,498 shares made by Michael M Rowe , and a net purchase of 14,820 shares made by Ellen R Strahlman .
In summary, during the past 3 months, insiders sold 0 shares of Eyenovia Inc (EYEN) in total and bought 77,071 shares, with a net purchase of 77,071 shares. During the past 18 months, 0 shares of Eyenovia Inc (EYEN) were sold and 1,949,933 shares were bought by its insiders, resulting in a net purchase of 1,949,933 shares.
Eyenovia Inc (EYEN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Eyenovia Inc Insider Transactions
Senju Pharmaceutical Co., Ltd. Mailing Address
Above is the net worth, insider trading, and ownership report for Senju Pharmaceutical Co., Ltd.. You might contact Senju Pharmaceutical Co., Ltd. via mailing address: 501 Fifth Avenue, Suite 1404, New York Ny 10017.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
